Remove 2008 Remove Packaging Remove Vaccines
article thumbnail

Guido Rasi steps down, handing the running of EMA to Emer Cooke

pharmaphorum

In his final message as head of the EMA, Rasi said the number of COVID-19 drugs and vaccines being developed by pharma companies is “encouraging,” and pointing to the agency’s pivotal role “in reviewing the available data packages to ensure that our usual high standards of safety, efficacy and quality are achieved and upheld.”.

article thumbnail

Prednisone for gout: Dosage, safety, and more

The Checkup by Singlecare

So, anyone taking it should avoid people who have highly infectious diseases like the flu or who recently received a live vaccine. According to studies from 2008 and 2018 , prednisone and non-steroidal anti-inflammatory drugs are equally effective treatment options for gout.

Dosage 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.

article thumbnail

Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure

PharmaShots

Founded Year: 2008 Total Employees: ~2110 Headquarters: Dublin, Ireland Market Cap: $1.7M The company strives to discover and develop therapeutic products under its business segments, including General Medicines, Specialty Medicines, and Vaccines. R&D Expenditure: $437.9M R&D Expenditure: $6.6B R&D Expenditure: $14.6B

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

In addition to serving as Associate Editor-in-Chief of the IEEE Open Access Journal of Circuits and Systems, she has been an Associate Editor of IEEE Transactions on Biomedical Circuits and Systems since 2008. Designation: Global Head Previous company: Merck Global Vaccines (2 yrs. LinkedIn Total experience: 26 yrs.

FDA 40
article thumbnail

Regulatory Landscape for Raw Materials: CMC Considerations

ISPE

In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP). Finally, the DP is packaged in a suitable container to ensure continued quality. Published 2008. This is followed by DP manufacturing, where the DS is formulated with excipients.